2015
DOI: 10.1534/g3.115.018564
|View full text |Cite
|
Sign up to set email alerts
|

Exome Sequencing: Current and Future Perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
133
1
5

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 186 publications
(139 citation statements)
references
References 79 publications
0
133
1
5
Order By: Relevance
“…These strategies usually rely on addressing the gene space, but many of them, such as RNA-Seq (Wang et al, 2010) or exome capture (Warr et al, 2015), are beyond reach of scientists working on crops of lesser economical importance, due to high cost involved or because an extensive preexisting genome sequence knowledge is required. Diversity Arrays Technology (Jaccoud et al, 2001) is an affordable, sequence independent alternative, which delivers several thousand genetic markers in a single assay.…”
Section: Discussionmentioning
confidence: 99%
“…These strategies usually rely on addressing the gene space, but many of them, such as RNA-Seq (Wang et al, 2010) or exome capture (Warr et al, 2015), are beyond reach of scientists working on crops of lesser economical importance, due to high cost involved or because an extensive preexisting genome sequence knowledge is required. Diversity Arrays Technology (Jaccoud et al, 2001) is an affordable, sequence independent alternative, which delivers several thousand genetic markers in a single assay.…”
Section: Discussionmentioning
confidence: 99%
“…Whereas whole genome sequencing does not require any a priori knowledge, for exome capture it is necessary to have some level of knowledge of the intron boundaries and gene content of the organism of interest. Because well‐annotated genomes improve probe design, high‐quality reference genomes and transcriptomes reduce the risk of false positives or missing important variants in the generated data set (Chamala et al., 2015; Warr et al., 2015). …”
mentioning
confidence: 99%
“…1,2 In recessive conditions, two of such variants have forcibly to be present in the same gene to cause disease, lowering the number of candidate genes associated with the pathology to only 5-10, genome-wide. 1,3,4 In contrast, any gene harboring one of these 400 variants in a heterozygous state represents potentially a gene associated with a dominant disorder, making it difficult to identify the cause of this class of genetic conditions ( Figure 1A). As a consequence, NGS-based studies appear to be almost 10-fold more efficient in detecting genes associated to recessive disorders as compared to dominant ones.…”
mentioning
confidence: 99%